943 studies found for:    Open Studies | "Prostatic Diseases"
Show Display Options
Rank Status Study
21 Recruiting Efficacy and Safety of Tamsulosin/Solifenacin Combination Therapy in Patients With Voiding Symptoms and Moderate to Severe Storage Symptoms Due to Benign Prostate Hyperplasia
Condition: Benign Prostate Hyperplasia
Interventions: Drug: Tamsulosin;   Drug: Solifenacin;   Drug: Solifenacin placebo
22 Recruiting Study to Evaluate Safety, Tolerability, and PK of GT0918 in Subjects With Metastatic Castrate Prostate Cancer
Condition: Metastatic Prostate Cancer
Intervention: Drug: GT0918
23 Available C11 Sodium Acetate PET/CT Imaging of PCa
Condition: Prostate Cancer
Intervention: Drug: Carbon-11 Sodium Acetate
24 Recruiting Study of the Clinical Utility of PSMA Imaging in the Evaluation of Men With Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: 18F DCFPyL- Radiopharmaceutica
25 Recruiting Study of ODX (Osteodex) in Metastatic Castration Resistant Prostate Cancer (CRPC)
Condition: Prostate Cancer Metastatic
Intervention: Drug: Osteodex
26 Recruiting Impact of Anticoagulants and Antiplatelets in Patients on Transurethral Resection of the Prostate
Conditions: Benign Prostatic Hyperplasia;   Prostate Cancer
27 Recruiting Prostate Artery Embolization for Symptomatic Benign Prostatic Hyperplasia
Condition: Benign Prostate Hyperplasia
Intervention: Procedure: Prostate artery embolization (PAE)
28 Not yet recruiting Preoperative Treatment With Topical Brimonidine Tartrate 0.2% on Intraocular Pressure (IOP) of Patients Undergoing Robotic Assisted Laporoscopic Prostatectomy (RALP)
Condition: Prostate Cancer
Interventions: Drug: brimonidine tartrate 0.2%;   Drug: Placebo
29 Recruiting SBRT for Oligometastatic Castration-Refractory Prostate Cancer
Condition: Prostate Cancer
Intervention: Radiation: SBRT
30 Not yet recruiting PET-CT/MRI in the Radiotherapy for Prostate Cancer
Condition: Prostate Cancer
Interventions: Radiation: PET-CT;   Radiation: PET-MRI
31 Recruiting 11C or 18F-Choline PET/CT and Whole Body MRI for Staging and Response Prediction in Metastatic Hormono-Sensitive Prostate Cancer Patients Receiving Enzalutamide
Condition: Prostate Cancer Metastatic
Interventions: Drug: Enzalutamide;   Procedure: 11C or 18F-Choline PET/CT;   Procedure: Whole body MRI;   Procedure: Bone scan
32 Recruiting 18F-FDG PET/CT and Whole Body MRI for Staging and Response Prediction in Castration-resistant Prostate Cancer Patients Receiving Enzalutamide
Condition: Prostate Cancer Metastatic
Interventions: Drug: Enzalutamide;   Device: 18-FDG PET/CT;   Device: Whole body MRI;   Device: Bone scan
33 Not yet recruiting Safety and Tolerability of Atezolizumab (ATZ) in Combination With Radium-223 Dichloride (R-223-D) in Metastatic Castrate-Resistant Prostate Cancer (CRPC) Progressed Following Treatment With an Androgen Pathway Inhibitor
Condition: Castrate-Resistant Prostate Cancer
Interventions: Drug: Atezolizumab;   Drug: Radium-223 dichloride
34 Recruiting A Study to Investigate the Impact of Abiraterone Acetate and Enzalutamide on Health-related Quality of Life, Participant-Reported Outcomes, and Medical Resource Use in Metastatic Castration-resistant Prostate Cancer Participants
Condition: Prostatic Neoplasms
35 Not yet recruiting Assessment of New Molecular Imaging Strategies for Prostate Cancer
Condition: Prostate Cancer
Intervention: Other: Molecular Imaging
36 Not yet recruiting Apalutamide Plus Intermittent Hormone Therapy Versus Intermittent Hormone Therapy Alone in Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Apalutamide;   Drug: IHT
37 Not yet recruiting Prospective Evaluation of 68Ga-PSMA PET-CT for Recurrence Detection of Prostate Cancer and Its Impact on Patient Management
Condition: Prostate Cancers
Intervention: Drug: 68Ga-(HBED-CC)-PSMA
38 Not yet recruiting 18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer
Condition: Prostate Neoplasm
Interventions: Device: CAT;   Radiation: Fluorine F 18 d-FMAU;   Other: Laboratory Biomarker Analysis;   Procedure: Multiparametric Magnetic Resonance Imaging;   Device: Positron Emission Tomography;   Device: Ultrasound
39 Not yet recruiting Abiraterone Acetate, Niclosamide, and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer
Conditions: Metastatic Prostate Carcinoma;   Recurrent Prostate Carcinoma;   Stage IV Prostate Cancer
Interventions: Drug: Abiraterone Acetate;   Drug: Niclosamide;   Drug: Prednisone
40 Not yet recruiting NBTXR3 Nanoparticles and EBRT or EBRT With Brachytherapy in the Treatment of Prostate Adenocarcinoma
Condition: Prostate Cancer
Interventions: Drug: NBTXR3 activated by IMRT only;   Drug: NBTXR3 activated by Brachytherapy & IMRT

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years